ORIGINAL ARTICLE

Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia

N Lubis¹, D Baylis¹, A Short¹, J Stebbing², A Teague², S Portsmouth², M Bower², M Nelson², B Gazzard²

¹ Imperial College School of Medicine, London
² Chelsea and Westminster Hospital, London

Correspondence to:
Correspondence to:
Dr Justin Stebbing, Department of Immunology, Chelsea and Westminster Hospital, 369 Fulham Road, SW10 9NH, UK;
j.stebbing{at}ic.ac.uk

Pneumocystis carinii pneumonia (PCP) remains a serious opportunistic infection in HIV infected individuals. Seasonal changes in climate are associated with changes within individual susceptibility to infection. The possibility of monthly variability in the incidence of PCP was therefore examined by means of a cohort study of a database of 8640 HIV infected individuals attending the Chelsea and Westminster Hospital. There were 792 cases of PCP diagnosed since 1985. A marked decline was observed in the incidence of PCP in mid-1992 coincident with the introduction of PCP prophylaxis. There was a further decline in 1996 after the introduction of highly active antiretroviral therapy. Despite no significant monthly variation in the mean attendance to clinic and CD4 count, both new and all cases of PCP were higher in January than in other months (15.9% and 14.5% of all cases, respectively). A correlation with low rainfall in January and new cases of PCP was observed. These data are consistent with an influence of climatic conditions on the presentation of PCP. The diagnosis of PCP is more common in winter months suggesting that this is a transmissible infection.

Keywords: Pneumocystis carinii pneumonia; seasonal variation

Abbreviations: HAART, highly active antiretroviral therapy; PCP, Pneumocystis carinii pneumonia

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Orkin, C., Stebbing, J., Nelson, M., Bower, M., Johnson, M., Mandalia, S., Jones, R., Moyle, G., Fisher, M., Gazzard, B. (2005). A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study). J Antimicrob Chemother 55: 246-251 [Abstract] [Full Text]  
• (2004). Hygieia. J. Epidemiol. Community Health 58: 260-260 [Full Text]